[ad_1]
Vaccines are two powerful weapons against a pandemic that has infected 54 million people worldwide and killed 1.3 million.
The news also comes at a time when Covid-19 disease cases are on the rise, as they hit new records in the United States and pushed some European countries to shut down again.
Stephen Hogg, president of Moderna, said in a telephone interview "We will have a vaccine that can stop COVID-19".
The company hopes to have enough safety data necessary to authorize the vaccine in the United States within the next week, and also expects to submit an application for emergency use of the vaccine in the coming weeks.
Moderna shares, which have more than quadrupled in price this year, were up 15 percent before the start of trading, and European stocks and Wall Street futures rose with the frequency of vaccine news developments.
“>
Moderna said Monday that its experimental vaccine to prevent Covid-19 is 94.5 percent effective, according to interim data from a late-stage clinical trial, becoming the second US pharmaceutical company to announce results that far exceed expectations in one week.
In addition to the Pfizer vaccine, which has also shown more than 90 percent efficacy and is awaiting further safety data and regulatory review, the United States could have two vaccines licensed for emergency use in December.
One of the main advantages of the Moderna vaccine is that it does not need to be stored in extremely cold temperatures like the Pfizer vaccine, which makes it easy to distribute.
Moderna expects the vaccine to be stable at normal refrigerant temperatures of 2 to 8 degrees Celsius for 30 days and can be stored for up to six months at minus 20 degrees Celsius.
In return, the Firees vaccine must be shipped and stored at minus 70 degrees Celsius, which is the normal temperature in the Antarctic winter. At normal coolant temperatures, it can be stored for up to five days.
Vaccines are two powerful weapons against a pandemic that has infected 54 million people worldwide and killed 1.3 million.
The news also comes at a time when Covid-19 disease cases are on the rise, as they hit new records in the United States and pushed some European countries to shut down again.
“We will have a vaccine that can stop Covid-19,” Moderna president Stephen Hugh said in a telephone interview.
The company hopes to have enough safety data necessary to authorize the vaccine in the United States within the next week, and also expects to submit an application for emergency use of the vaccine in the coming weeks.
Moderna shares, which have more than quadrupled in price this year, were up 15 percent before the start of trading, and European stocks and Wall Street futures rose with the frequency of vaccine news developments.
[ad_2]
